Uploaded July 2026 | Updated September 2026, 3 weeks ago

---

Elysium reported pilot data suggesting its NAD+ supplement BASIS reduced the frequency and severity of several menopause symptoms in women after just seven days. The study also found changes in estrogen metabolism biomarkers, pointing to a potential new avenue for supporting hormonal health beyond conventional hormone replacement therapy, although larger controlled trials are needed.

Full Episode on YouTube, Spotify and Apple Podcast. Link in the comment.

#LongevityTechnologyUnlocked #LongevityPodcast #Menopause #Elysium #NAD #WomensHealth